vs
EXACT SCIENCES CORP（EXAS）与LCI INDUSTRIES（LCII）财务数据对比。点击上方公司名可切换其他公司
LCI INDUSTRIES的季度营收约是EXACT SCIENCES CORP的1.1倍（$932.7M vs $878.4M），LCI INDUSTRIES净利率更高（2.0% vs -9.8%，领先11.8%），EXACT SCIENCES CORP同比增速更快（23.1% vs 16.1%），EXACT SCIENCES CORP自由现金流更多（$120.4M vs $64.3M），过去两年EXACT SCIENCES CORP的营收复合增速更高（17.4% vs -1.8%）
Exact Sciences是总部位于美国威斯康星州麦迪逊的分子诊断企业，专注于早期癌症检测领域。公司核心产品覆盖结直肠癌筛查与预防场景，其中Cologuard是全球首个获批的结直肠癌粪便DNA检测产品，同时还提供其他多种癌症的筛查服务及精准肿瘤检测解决方案。
拉奇核心工业有限公司前身为巴基斯坦帝国化学工业公司，是一家总部位于卡拉奇的巴基斯坦综合性企业集团，业务覆盖聚酯、医药、农用化学品、纯碱及兽药等多品类产品的研发生产，在巴基斯坦本土工业领域拥有重要市场地位。
EXAS vs LCII — 直观对比
营收规模更大
LCII
是对方的1.1倍
$878.4M
营收增速更快
EXAS
高出7.0%
16.1%
净利率更高
LCII
高出11.8%
-9.8%
自由现金流更多
EXAS
多$56.1M
$64.3M
两年增速更快
EXAS
近两年复合增速
-1.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $878.4M | $932.7M |
| 净利润 | $-86.0M | $18.7M |
| 毛利率 | 70.1% | 22.1% |
| 营业利润率 | -9.4% | 3.8% |
| 净利率 | -9.8% | 2.0% |
| 营收同比 | 23.1% | 16.1% |
| 净利润同比 | 90.1% | 95.7% |
| 每股收益（稀释后） | $-0.45 | $0.79 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EXASLCII
| Q4 25 | $878.4M | $932.7M | ||
| Q3 25 | $850.7M | $1.0B | ||
| Q2 25 | $811.1M | $1.1B | ||
| Q1 25 | $706.8M | $1.0B | ||
| Q4 24 | $713.4M | $803.1M | ||
| Q3 24 | $708.7M | $915.5M | ||
| Q2 24 | $699.3M | $1.1B | ||
| Q1 24 | $637.5M | $968.0M |
净利润EXASLCII
| Q4 25 | $-86.0M | $18.7M | ||
| Q3 25 | $-19.6M | $62.5M | ||
| Q2 25 | $-1.2M | $57.6M | ||
| Q1 25 | $-101.2M | $49.4M | ||
| Q4 24 | $-864.6M | $9.5M | ||
| Q3 24 | $-38.2M | $35.6M | ||
| Q2 24 | $-15.8M | $61.2M | ||
| Q1 24 | $-110.2M | $36.5M |
毛利率EXASLCII
| Q4 25 | 70.1% | 22.1% | ||
| Q3 25 | 68.6% | 24.4% | ||
| Q2 25 | 69.3% | 24.4% | ||
| Q1 25 | 70.8% | 24.1% | ||
| Q4 24 | 69.0% | 21.1% | ||
| Q3 24 | 69.4% | 24.0% | ||
| Q2 24 | 69.8% | 25.3% | ||
| Q1 24 | 70.0% | 23.1% |
营业利润率EXASLCII
| Q4 25 | -9.4% | 3.8% | ||
| Q3 25 | -3.0% | 7.3% | ||
| Q2 25 | -0.3% | 7.9% | ||
| Q1 25 | -13.6% | 7.8% | ||
| Q4 24 | -122.8% | 2.0% | ||
| Q3 24 | -5.6% | 5.9% | ||
| Q2 24 | -3.8% | 8.6% | ||
| Q1 24 | -16.7% | 6.0% |
净利率EXASLCII
| Q4 25 | -9.8% | 2.0% | ||
| Q3 25 | -2.3% | 6.0% | ||
| Q2 25 | -0.1% | 5.2% | ||
| Q1 25 | -14.3% | 4.7% | ||
| Q4 24 | -121.2% | 1.2% | ||
| Q3 24 | -5.4% | 3.9% | ||
| Q2 24 | -2.3% | 5.8% | ||
| Q1 24 | -17.3% | 3.8% |
每股收益（稀释后）EXASLCII
| Q4 25 | $-0.45 | $0.79 | ||
| Q3 25 | $-0.10 | $2.55 | ||
| Q2 25 | $-0.01 | $2.29 | ||
| Q1 25 | $-0.54 | $1.94 | ||
| Q4 24 | $-4.69 | $0.37 | ||
| Q3 24 | $-0.21 | $1.39 | ||
| Q2 24 | $-0.09 | $2.40 | ||
| Q1 24 | $-0.60 | $1.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $964.7M | $222.6M |
| 总债务越低越好 | — | $945.2M |
| 股东权益账面价值 | $2.4B | $1.4B |
| 总资产 | $5.9B | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.69× |
8季度趋势，按日历期对齐
现金及短期投资EXASLCII
| Q4 25 | $964.7M | $222.6M | ||
| Q3 25 | $1.0B | $199.7M | ||
| Q2 25 | $858.4M | $191.9M | ||
| Q1 25 | $786.2M | $231.2M | ||
| Q4 24 | $1.0B | $165.8M | ||
| Q3 24 | $1.0B | $161.2M | ||
| Q2 24 | $946.8M | $130.4M | ||
| Q1 24 | $652.1M | $22.6M |
总债务EXASLCII
| Q4 25 | — | $945.2M | ||
| Q3 25 | — | $947.8M | ||
| Q2 25 | — | $948.0M | ||
| Q1 25 | — | $938.3M | ||
| Q4 24 | — | $757.3M | ||
| Q3 24 | — | $822.5M | ||
| Q2 24 | — | $829.7M | ||
| Q1 24 | — | $855.3M |
股东权益EXASLCII
| Q4 25 | $2.4B | $1.4B | ||
| Q3 25 | $2.5B | $1.4B | ||
| Q2 25 | $2.5B | $1.4B | ||
| Q1 25 | $2.4B | $1.4B | ||
| Q4 24 | $2.4B | $1.4B | ||
| Q3 24 | $3.2B | $1.4B | ||
| Q2 24 | $3.2B | $1.4B | ||
| Q1 24 | $3.1B | $1.4B |
总资产EXASLCII
| Q4 25 | $5.9B | $3.2B | ||
| Q3 25 | $5.9B | $3.2B | ||
| Q2 25 | $5.8B | $3.2B | ||
| Q1 25 | $5.7B | $3.1B | ||
| Q4 24 | $5.9B | $2.9B | ||
| Q3 24 | $6.7B | $3.0B | ||
| Q2 24 | $6.7B | $3.0B | ||
| Q1 24 | $6.4B | $3.0B |
负债/权益比EXASLCII
| Q4 25 | — | 0.69× | ||
| Q3 25 | — | 0.70× | ||
| Q2 25 | — | 0.68× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | 0.55× | ||
| Q3 24 | — | 0.58× | ||
| Q2 24 | — | 0.60× | ||
| Q1 24 | — | 0.63× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $151.7M | $78.9M |
| 自由现金流经营现金流 - 资本支出 | $120.4M | $64.3M |
| 自由现金流率自由现金流/营收 | 13.7% | 6.9% |
| 资本支出强度资本支出/营收 | 3.6% | 1.6% |
| 现金转化率经营现金流/净利润 | — | 4.22× |
| 过去12个月自由现金流最近4个季度 | $356.8M | $278.3M |
8季度趋势，按日历期对齐
经营现金流EXASLCII
| Q4 25 | $151.7M | $78.9M | ||
| Q3 25 | $219.9M | $97.2M | ||
| Q2 25 | $89.0M | $112.2M | ||
| Q1 25 | $30.8M | $42.7M | ||
| Q4 24 | $47.1M | $106.6M | ||
| Q3 24 | $138.7M | $78.4M | ||
| Q2 24 | $107.1M | $192.9M | ||
| Q1 24 | $-82.3M | $-7.7M |
自由现金流EXASLCII
| Q4 25 | $120.4M | $64.3M | ||
| Q3 25 | $190.0M | $80.9M | ||
| Q2 25 | $46.7M | $99.5M | ||
| Q1 25 | $-365.0K | $33.7M | ||
| Q4 24 | $10.7M | $95.7M | ||
| Q3 24 | $112.6M | $68.3M | ||
| Q2 24 | $71.2M | $180.2M | ||
| Q1 24 | $-120.0M | $-16.3M |
自由现金流率EXASLCII
| Q4 25 | 13.7% | 6.9% | ||
| Q3 25 | 22.3% | 7.8% | ||
| Q2 25 | 5.8% | 9.0% | ||
| Q1 25 | -0.1% | 3.2% | ||
| Q4 24 | 1.5% | 11.9% | ||
| Q3 24 | 15.9% | 7.5% | ||
| Q2 24 | 10.2% | 17.1% | ||
| Q1 24 | -18.8% | -1.7% |
资本支出强度EXASLCII
| Q4 25 | 3.6% | 1.6% | ||
| Q3 25 | 3.5% | 1.6% | ||
| Q2 25 | 5.2% | 1.2% | ||
| Q1 25 | 4.4% | 0.9% | ||
| Q4 24 | 5.1% | 1.4% | ||
| Q3 24 | 3.7% | 1.1% | ||
| Q2 24 | 5.1% | 1.2% | ||
| Q1 24 | 5.9% | 0.9% |
现金转化率EXASLCII
| Q4 25 | — | 4.22× | ||
| Q3 25 | — | 1.55× | ||
| Q2 25 | — | 1.95× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | — | 11.17× | ||
| Q3 24 | — | 2.20× | ||
| Q2 24 | — | 3.15× | ||
| Q1 24 | — | -0.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EXAS
| Screening | $695.1M | 79% |
| Precision Oncology | $183.2M | 21% |
LCII
| Travel Trailer And Fifth Wheels | $378.4M | 41% |
| Chassis Chassis Partsand Slideout Mechanisms | $206.1M | 22% |
| Furnitureand Mattresses | $120.4M | 13% |
| Appliances | $69.9M | 7% |
| Other Products | $69.1M | 7% |
| Axlesand Suspension Solutions | $62.3M | 7% |
| Motorhomes | $34.2M | 4% |
